STOCK TITAN

[6-K] Compugen Ltd Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

TL;DR Routine 6-K alerts investors to 2025 AGM; no material impact expected.

This 6-K serves only to formally notify shareholders of the upcoming AGM and make proxy materials publicly available. Such disclosures are a standard governance requirement for foreign private issuers listed in the U.S. Because no agenda items, board changes, or shareholder proposals are detailed here, the filing is largely administrative and should not affect valuation or trading dynamics.

TL;DR Neutral filing; provides meeting date but no financial insight.

Investors receive the meeting date—16 Sept 2025—and confirmation that materials are incorporated into the existing F-3 shelf. Absent financial data or strategic announcements, the document is not a catalyst for the stock. Monitor the forthcoming proxy statement for any proposals that could influence capital structure or governance.



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025
Commission File Number 000-30902

COMPUGEN LTD.
(Translation of registrant’s name into English)

26 Harokmim Street
Holon 5885849, Israel
(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒  Form 40-F ☐


Compugen Ltd.

On or about August 6, 2025, Compugen Ltd. (the “Company”) took action to distribute copies of its proxy statement to its shareholders and to mail to its shareholders of record a proxy statement for an annual general meeting of shareholders to be held on Tuesday, September 16, 2025, at 6:00 PM (Israel time) in Israel.
 
A copy of the notice of 2025 annual general meeting of shareholders of the Company, proxy statement and proxy card are attached to this Form 6-K as Exhibit 99.1.
 
The information contained in this Form 6-K is hereby incorporated by reference into the Company’s Registration Statements on Form F-3, File No. 333-270985.



Exhibits

Exhibit
Number

99.1

Description of Exhibit

Notice of 2025 annual general meeting of shareholders of Compugen Ltd., proxy statement and proxy card.


 
Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
COMPUGEN LTD.
 
Date: August 6, 2025
By: 
/s/ Eran Ben Dor          
 
 
 
Eran Ben Dor
General Counsel
 




 


 

Compugen

NASDAQ:CGEN

CGEN Rankings

CGEN Latest News

CGEN Latest SEC Filings

CGEN Stock Data

136.53M
91.62M
2.12%
17.42%
1.47%
Biotechnology
Healthcare
Link
Israel
Holon